ANKIAL Pharma
Mitochondrial-targeted heart drug
- B2B
About ANKIAL Pharma
Development of a patented mitochondrial drug to treat hypertrophic cardiomyopathy, progressing from preclinical studies to regulatory approval.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1–10 employees
- Headquarters
- Bordeaux, Nouvelle-Aquitaine, France
- Founded
- 2023
- Website
- ankialpharma.com
ANKIAL Pharma at a glance
ANKIAL Pharma is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Bordeaux, Nouvelle-Aquitaine, France.
ANKIAL Pharma was founded in 2023.
ANKIAL Pharma has 1–10 employees.
Selling to companies like ANKIAL Pharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies